(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

VETORES ADENOVIRAIS PARA TERAPIA GÊNICA

Em AnáliseInvention PatentPCT · US2021064979

Application data

Number

112023012461

Type

Invention Patent

Filing

12/22/2021

Publication

09/12/2023

PCT

US2021064979

Progress at the INPI

  1. Filing12/22/21
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 12/22/2021. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 09/12/2023. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ENSOMA, INC.

US

Inventors

A. B. (pessoa física)

US

S. R. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

63/129,233 · 12/22/2020

Abstract

VETORES ADENOVIRAIS PARA TERAPIA GÊNICA. A presente invenção se refere a vetores adenovirais caracterizados por transdução eficiente de HSCs, por exemplo, para terapia gênica in vivo. A presente invenção inclui, dentre outras coisas, genomas e vetores Ad3, Ad7, Ad11, Ad14, Ad16, Ad21, Ad34, Ad37 e Ad50. Vetores e genomas Ad3, Ad7, Ad11, Ad14, Ad16, Ad21, Ad34, Ad37 e Ad50 da presente invenção podem incluir cargas úteis terapêuticas.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

09/12/2023

RPI 2749

Alteração de dados cadastrais

#1.1

07/04/2023

RPI 2739

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.